Have you ever wondered what happens in a University? Ever been curious about the research done at the University of Leeds and what relevance it has to you and to the Leeds and Yorkshire area? Be Curious 2017 will be held at the University of Leeds, Parkinson building on Saturday 25 March 2017, 10am -...
Despite the success of vaccines produced from "virus-like particles" (VLPs) for hepatitis B and human papilloma viruses, poliovirus VLPs have proved to be too unstable to make practical vaccines. Now, a research team from the Faculty of Biological Sciences (FBS) has found a new way to modify these VLPs, also known as "empty capsids", by...
The MRC, the South African MRC, and GSK have teamed up under the Newton Fund in order to tackle non-communicable diseases (NCDs) in Africa. The funders will collectively invest approximately £5m to support UK and South African academics to collaborate with scientists from GSK’s Africa NCD Open Lab in order to enhance our understanding of...
Business and scientists in the UK are being invited to contribute their thoughts how on the Industrial Strategy Challenge Fund can support them. The fund, which was announced by the Prime Minister at the 2016 CBI Annual Conference, will help identify and develop UK industries that are fit for the future, driving progress in technologies...
Professor Alex Breeze of the Astbury Centre and Faculty of Biological Sciences has received significant funding for key pancreatic cancer research. The research will be carried out in collaboration with Professor Mike Waring of Newcastle University. The project is part of five projects that have received funding from the national charity Pancreatic Cancer Research Fund...
UK-wide workshops will allow businesses and scientists to input on how the cross-disciplinary fund can support industry. Business and scientists in the UK are being invited to contribute their thoughts how on the Industrial Strategy Challenge Fund can support them. The fund, which was announced by the Prime Minister at the 2016 CBI Annual Conference,...
MedImmune, the global biologics research and development arm of AstraZeneca, and a consortium of Leeds, Cambridge, Manchester and Sheffield universities has secured a Collaborative Training Partnership, structured as 12 PhD studentships. The studentships are designed to invest in the training of the next generation of scientists for the wider bioeconomy and research base, providing access...
Leeds University has launched a new MSc course on Biopharmaceutical Development: Biopharmaceutical Development is a unique professional training programme designed and developed in collaboration with a multinational Contract Research Organisation, Covance. This programme is aimed at high calibre candidates who wish to translate their previous training in biological science disciplines into a career in the...
For the field of cancer biology, designing drugs against a molecule that many deem ‘undruggable’ has seemed like a distant possibility. But scientists don’t give up easily. The molecule in question is called Myc. And it’s is a powerful controller, switching genes on and off to dictate when cells live, die or multiply. It’s also...
A virus that causes childhood coughs and colds could help in the fight against primary liver cancer. Reovirus stimulates the body’s own immune system to kill off the cancerous cells, researchers from the University of Leeds discovered. In addition, Reovirus is able to kill off the hepatitis C virus – a common cause of primary...